Learning Objectives: 

1.) Understand pulmonary hypertension (PH) versus PAH and classification. 

2.) Discuss the basic physiology considerations of PH/PAH.

3.) Learn about PAH specific to connective tissue disease.

     A. Screen and treatment  

     B. Morbidity and mortality

     C. How PAH associated with connective tissue disease is different

Disclosures:

Clinical research trials:

- Janssen (Actelion), also part of Johnson and Johnson

- Bayer

- United Therapeutics 

Advisory board:

- United Therapeutics

- Acceleron

 CME Code: QUHBES

Location: virtual (by WebEx only)
Directions: If you are having trouble accessing WebEx, please contact Isaac Smith at isaac.smith063@duke.edu. 

Streaming: Yes, via WebEx. Link:  https://dukemed.webex.com/meet/is120 

Meeting Number/Access Code: 470 543 135  (you will not need this if you use link above)

Call-in number: 1-650-479-3207